Dustin Cavida, PharmD

Associate Medical Director
Amgen United States

Poster(s):

• (75) What aspects of treatment are important to people living with Neuromyelitis Optica Spectrum Disorder (NMOSD)? A qualitative study
  Wednesday, October 29, 2025

• (380) Treatment patterns among patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A real-world evidence study
  Wednesday, October 29, 2025